Europe Safety Syringes Market Overview
Injections are one of the most common health-care procedures. Every year at least 16 billion injections are administered worldwide. The vast majority – around 90% – are given in curative care. Immunization injections account for around 5% of all injections.
Europe Safety Syringes Industry Segment Analysis
With the ever rising demand to protect healthcare professionals from accidental needle-stick injuries and hospital-acquired infections, there has been an upsurge in demand for safety syringes. Further, rising occurrences of needlestick injuries, government initiatives, and legislation to integrate the practice of safety syringes, improved safety mechanisms for syringes and favorable reimbursement policies are supporting the growth of Safety syringes market in European countries. Presently, several countries have enforced regulations to ensure the compulsory use of safety syringes with an aim of preventing needle stick injuries and restrict needle re-use. However, accessibility to alternate drug delivery methods, expensiveness of safety syringes, ignorance in low-income regions due to unawareness about healthcare and safety issues are few factors preventing the steady growth of Europe safety syringes market.
Europe Safety Syringes Market Forecast Report (2018-2023)
Europe Safety Syringes Market is estimated at USD 1.42 Billion in 2018 and is predicted to reach USD 2.09 Billion by 2023, growing at a CAGR of 7.97%.
Europe Safety Syringes Market Regional Outlook
The Europe safety syringes market can be classified on the basis of technology into Retractable and Non-Retractable safety syringes. The retractable syringes market is further segmented into Manual or Automatic syringes. And the non-retractable safety syringes are sub-segmented into sliding needle cover syringes, sheathing tube syringes, and hinged needle cover syringes. Non-retractable safety syringes hold the major share of sales in the European countries while the retractable safety syringes segment is projected to rise at a higher CAGR during the forecast period. Furthermore, on the basis of therapy, the safety syringes market can be categorized under Insulin, Glucagon-like peptide-1 (GLP-1), Tuberculosis and Growth Hormones. Moreover, taking into account end users, the Europe safety syringe market is branded under hospitals and home care segments.
Geographically, the Europe safety syringe market is segmented and analyzed U.K, Italy, Spain, France, and Germany. European countries together hols the second position in terms of revenue as well as volume in the global safety syringes market. The United Kingdom represents the largest share of the Europe safety syringes market, followed by Germany. While Spain is expected to record highest CAGR within the forecast period. Further, the growing demand for prefilled syringes fortified with safety features in this region is also adding to the market growth.
Major Key Players
Some of the major companies operating in the Europe safety syringes market
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Technology
5.1.1 Retractable safety syringes
5.1.1.1 Automatic retractable safety syringes
5.1.1.2 Manual retractable safety syringes
5.1.2 Non-Retractable safety syringes
5.1.2.1 Sheathing tube syringes
5.1.2.2 Sliding needle cover syringes
5.1.2.3 Hinged needle cover syringes
5.2 By Therapy
5.2.1 Insulin
5.2.2 Glucagon-like peptide-1 (glp-1)
5.2.3 Tuberculosis
5.2.4 Growth hormones
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Care
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton, Dickinson & Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Covidien plc
8.3 Revolutions Medical Corporation
8.4 Retractable Technologies, Inc.
8.5 Smiths Medical
8.6 Unilife Corporation
8.7 Terumo Corporation
8.8 Sol-Millennum
8.9 Ultimed, Inc.
8.10 Axel Bio Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
